DC
FDMT icon

Decheng Capital’s 4D Molecular Therapeutics FDMT Stock Holding History

Decheng Capital’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-44,311
Closed -$332K – 17
2025
Q4 		$332K Sell
44,311
-48,437
-52% -$491K 0.04% 17
2025
Q3 		$806K Sell
92,748
-146,762
-61% -$877K 0.14% 18
2025
Q2 		$889K Sell
239,510
-96,005
-29% -$337K 0.22% 18
2025
Q1 		$1.08M Sell
335,515
-64,485
-16% -$304K 0.3% 22
2024
Q4 		$2.23M Buy
400,000
+2,165
+0.5% +$17K 0.48% 23
2024
Q3 		$4.3M Buy
397,835
+50,000
+14% +$830K 1.02% 17
2024
Q2 		$7.3M Hold
347,835
– – 2.24% 12
2024
Q1 		$11.1M Buy
+347,835
New +$8.87M 1.49% 8

Other funds holding FDMT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return